Literature DB >> 31933944

Increased expression of O-GlcNAc transferase (OGT) is a biomarker for poor prognosis and allows tumorigenesis and invasion in colon cancer.

Daogun Xu1,2, Wei Wang1,3, Tun Bian2, Weifang Yang1,3, Minghai Shao1,3, Haihua Yang1,3.   

Abstract

Recent studies suggest that Elevated O-GlcNAcylation by increased O-GlcNAc transferase (OGT) and/or decreasing O-GlcNAcase (OGA) levels is associated with cancer initiation, progression, invasion, and metastasis. However, the function of OGT in colon cancer tumorigeneses remains unclear. Here, we showed OGT expression is elevated in human colon cancer tissue compared with adjacent normal tissue, and cases with higher OGT expression had shorter survival time. Additionally, OGT mRNA expression was positively correlated with pathologic TNM stage from TCGA public database. Finally, we found knock-down of OGT expression by RNA interference inhibits cell proliferation, migration and invasion in colon cancer cell lines. Taken together, this study imply that elevated OGT expression had an important function in colon cancer formation and progression, and OGT may be a valuable prognostic factor and therapeutic target. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Colon cancer; O-GlcNAc transferase; metastasis; proliferation

Year:  2019        PMID: 31933944

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  7 in total

1.  O-GlcNAc Transferase (OGT) Protects Cerebral Neurons from Death During Ischemia/Reperfusion (I/R) Injury by Modulating Drp1 in Mice.

Authors:  Jingru Zhao; Lipeng Dong; Tiantian Huo; Jinming Cheng; Xiaojuan Li; Xiaojuan Huangfu; Sujuan Sun; Hebo Wang; Litao Li
Journal:  Neuromolecular Med       Date:  2021-10-27       Impact factor: 4.103

2.  Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer.

Authors:  Shirley James; Jayasekharan S Aparna; Anu Babu; Aswathy Mary Paul; Manendra Babu Lankadasari; Subha R Athira; Sreesha S Kumar; Yadu Vijayan; Narayanan N Namitha; Sabira Mohammed; Girijadevi Reshmi; Kuzhuvelil B Harikumar
Journal:  Biomolecules       Date:  2021-04-29

Review 3.  Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies.

Authors:  Ninon Very; Ikram El Yazidi-Belkoura
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

Review 4.  Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

Authors:  Divya Thomas; Ashok Kumar Rathinavel; Prakash Radhakrishnan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-11-04       Impact factor: 10.680

Review 5.  Functional Analysis of O-GlcNAcylation in Cancer Metastasis.

Authors:  Donglu Wu; Jingji Jin; Zhidong Qiu; Da Liu; Haoming Luo
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

Review 6.  The Role of Glycosyltransferases in Colorectal Cancer.

Authors:  Cecilia Fernández-Ponce; Noelia Geribaldi-Doldán; Ismael Sánchez-Gomar; Roberto Navarro Quiroz; Linda Atencio Ibarra; Lorena Gomez Escorcia; Ricardo Fernández-Cisnal; Gustavo Aroca Martinez; Francisco García-Cózar; Elkin Navarro Quiroz
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

7.  FOXO1 gene involvement in a non-rhabdomyosarcomatous neoplasm.

Authors:  Matthias S Matter; Beata Bode-Lesniewska; Simon Haefliger; Muriel Genevay; Michel Bihl; Romina Marone; Daniel Baumhoer; Michael Papaloizos
Journal:  Virchows Arch       Date:  2021-01-28       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.